UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

March 31, 2026

Life Sciences Voice Top Five Newsletter

April 22, 2025

Autoimmune-Stricken Patients Respond to Allogeneic CAR-T Treatment

July 18, 2024

Must Read

Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

July 3, 2026

Top 10 Reasons Precision Medicine Requires Better Data Integration

July 3, 2026

Why Pharma Supply Chains Need a Resilience-First Strategy

July 3, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

BridgeBio Advances Attruby Launch and Three Late-Stage Drug Programs as It Secures New Investment

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

Ipsen to Acquire Memo and Phase 2 BKPyV Antibody Potravitug in Deal Worth Up to €700 Million

Zymeworks to Acquire Theravance in $929 Million Deal

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Top 10 Reasons Precision Medicine Requires Better Data Integration

Why Pharma Supply Chains Need a Resilience-First Strategy

Top 10 Real-World Use Cases for AI in Clinical Development

Why Medical Affairs Teams Need New Skills for the Next Decade

Commercial

Eli Lilly provides a $1.4 billion gene therapy contract to struggling Sangamo

Editor Picks

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Life Sciences Voice Top Five Newsletter

Autoimmune-Stricken Patients Respond to Allogeneic CAR-T Treatment

Must Read

Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

Top 10 Reasons Precision Medicine Requires Better Data Integration

Why Pharma Supply Chains Need a Resilience-First Strategy

Hot Topics

About Us

Follow Us